Abstract
Purpose: To determine the efficacy of transdermal clonidine for alleviating tamoxifen-induced hot flashes in women with a history of breast cancer. Patients and Methods: A randomized, double-blind, crossover design was used in this prospective study. Women with a history of breast cancer who were receiving tamoxifen and suffering from hot flashes were potentially eligible for this protocol study. Results: Clonidine did reduce hot-flash frequency to a degree that was statistically impressive (P < .0001), but clinically moderate (20% reduction from baseline). It also decreased hot- flash severity (P = .02, 10% reduction from baseline). Clonidine was related to increased mouth dryness (P < .001), constipation (P < .02), itchiness under the patch (P < .01), and drowsiness (P < .05). Conclusion: Better means are needed to alleviate hot flashes among patients in whom estrogen therapy is contraindicated.
Original language | English (US) |
---|---|
Pages (from-to) | 155-158 |
Number of pages | 4 |
Journal | Journal of Clinical Oncology |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1994 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research